TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ALDX

Aldeyra Therapeutics, Inc.

Healthcare · Biotechnology

1.40$ +0.7% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for Aldeyra Therapeutics, Inc. (ALDX): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/04/2026.

Next report 11/04/2026
Last report 08/13/2026
Earnings surprise by quarter (%)
Q3 23 · 44.0 % 23 Q4 23 · 42.9 % 23 Q1 24 · -27.3 % 24 Q2 24 · -100.0 % 24 Q3 24 · 3.9 % 24 Q4 24 · -22.7 % 24 Q1 25 · 30.3 % 25 Q2 25 · 23.8 % 25 Q3 25 · 23.5 % 25 Q4 25 · 29.0 % 25 Q1 26 · 50.0 % 26 Q2 26 · -45.5 % 26

EPS estimate beaten

Full history 27 of 49 quarters (55%)
Last 16 quarters 12 of 16 quarters (75%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 07/30/2026 Aldeyra Therapeutics, Inc. (ALDX): Entry into a Material Definitive Agreement; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/15/2026 Aldeyra Therapeutics, Inc. (ALDX): Other Events · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?